Skip to main content
SpringerLink
Log in
Book cover

Clinical Nephrogeriatrics pp 103–122Cite as

Glomerulopathies in the Elderly

  • Chapter
  • First Online:

  • 486 Accesses

Abstract

The assessment of glomerular disease in the elderly has its own set of unique challenges. Issues range from controversies in the diagnosis and treatment of specific disease entities, the spectrum of multi-morbidity, to the competing balance of conservative care to maximise quality of life with more aggressive/interventional treatment options. The range of lesions and relative frequency of each individual histological lesion observed in the elderly patient biopsied for renal dysfunction is different to that observed in younger patients. This chapter focusses on the commonest glomerulopathies encountered in elderly patients, and reviews the available treatment strategies, with attention to the nuances to the older patient.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Rule AD, Amer H, Cornell LD, Taler SJ, Cosio FG, Kremers WK, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med. 2010;152(9):561–7.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: with an emphasis on the glomeruli. Kidney Int. 2012;82(3):270–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33(4):278–85.

    Article  CAS  PubMed  Google Scholar 

  4. Hogan JJ, Mocanu M, Berns JS. The native kidney biopsy: update and evidence for best practice. Clin J Am Soc Nephrol. 2016;11(2):354–62.

    Article  CAS  PubMed  Google Scholar 

  5. Zhu P, Zhou FD, Zhao MH. The renal histopathology spectrum of elderly patients with kidney diseases: a study of 430 patients in a single Chinese center. Medicine (Baltimore). 2014;93(28):e226.

    Article  Google Scholar 

  6. Yokoyama H, Sugiyama H, Sato H, Taguchi T, Nagata M, Matsuo S, et al. Renal disease in the elderly and the very elderly Japanese: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16(6):903–20.

    Article  PubMed  Google Scholar 

  7. Verde E, Quiroga B, Rivera F, Lopez-Gomez JM. Renal biopsy in very elderly patients: data from the Spanish registry of glomerulonephritis. Am J Nephrol. 2012;35(3):230–7.

    Article  PubMed  Google Scholar 

  8. Rollino C, Ferro M, Beltrame G, Quattrocchio G, Massara C, Quarello F, et al. Renal biopsy in patients over 75: 131 cases. Clin Nephrol. 2014;82(4):225–30.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Nair R, Bell JM, Walker PD. Renal biopsy in patients aged 80 years and older. Am J Kidney Dis. 2004;44(4):618–26.

    Article  PubMed  Google Scholar 

  10. Moutzouris DA, Herlitz L, Appel GB, Markowitz GS, Freudenthal B, Radhakrishnan J, et al. Renal biopsy in the very elderly. Clin J Am Soc Nephrol. 2009;4(6):1073–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Harmankaya O, Okuturlar Y, Kocoglu H, Kaptanogullari H, Yucel SK, Ozkan H, et al. Renal biopsy in the elderly: a single-center experience. Int Urol Nephrol. 2015;47(8):1397–401.

    Article  PubMed  Google Scholar 

  12. Haas M, Spargo BH, Wit E-JC, Meehan SM. Etiologies and outcome of acute renal insufficiency in older adults: a renal biopsy study of 259 cases. Am J Kidney Dis. 2000;35(3):433–47.

    Article  CAS  PubMed  Google Scholar 

  13. Brown CM, Scheven L, O’Kelly P, Dorman AM, Walshe JJ. Renal histology in the elderly: indications and outcomes. J Nephrol. 2012;25(2):240–4.

    Article  PubMed  Google Scholar 

  14. Perkowska-Ptasinska A, Deborska-Materkowska D, Bartczak A, Stompor T, Liberek T, Bullo-Piontecka B, et al. Kidney disease in the elderly: biopsy based data from 14 renal centers in Poland. BMC Nephrol. 2016;17(1):194.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Liangos O, Wald R, O’Bell JW, Price L, Pereira BJ, Jaber BL. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol. 2006;1(1):43–51.

    Article  PubMed  Google Scholar 

  16. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int. 1996;50(3):811–8.

    Article  CAS  PubMed  Google Scholar 

  17. Death NCEiPOa. NCEPOD acute kidney injury: adding insult to injury report. 2009. Available from: http://www.ncepod.org.uk/2009.

  18. Carter CE, Gansevoort RT, Scheven L, Heerspink HJ, Shlipak MG, de Jong PE, et al. Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events. Clin J Am Soc Nephrol. 2012;7(4):595–603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Fotheringham J, Campbell MJ, Fogarty DG, El Nahas M, Ellam T. Estimated albumin excretion rate versus urine albumin-creatinine ratio for the estimation of measured albumin excretion rate: derivation and validation of an estimated albumin excretion rate equation. Am J Kidney Dis. 2014;63(3):405–14.

    Article  CAS  PubMed  Google Scholar 

  20. Sharma SG, Bomback AS, Radhakrishnan J, Herlitz LC, Stokes MB, Markowitz GS, et al. The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol. 2013;8(10):1718–24.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dhaun N, Bellamy CO, Cattran DC, Kluth DC. Utility of renal biopsy in the clinical management of renal disease. Kidney Int. 2014;85(5):1039–48.

    Article  PubMed  Google Scholar 

  22. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: membranous nephropathy. Am J Kidney Dis. 2015;66(3):e15–7.

    Article  PubMed  Google Scholar 

  23. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc. 2004;19(3):574–9.

    CAS  Google Scholar 

  24. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ. Anti-phospholipase A(2) receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol. 2011;6(6):1286–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Deegens JK, Wetzels JF. Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging. 2007;24(9):717–32.

    Article  CAS  PubMed  Google Scholar 

  27. Lefaucheur C, Stengel B, Nochy D, Martel P, Hill GS, Jacquot C, et al. Membranous nephropathy and cancer: epidemiologic evidence and determinants of high-risk cancer association. Kidney Int. 2006;70(8):1510–7.

    Article  CAS  PubMed  Google Scholar 

  28. Ruggenenti P, Fervenza FC, Remuzzi G. Treatment of membranous nephropathy: time for a paradigm shift. Nat Rev Nephrol. 2017;13(9):563–79.

    Article  CAS  PubMed  Google Scholar 

  29. KDIGO. KDIGO clinical practice guidelines for glomerulonephritis. Kidney Int. 2012;Suppl 2.

    Google Scholar 

  30. Perna A, Schieppati A, Zamora J, Giuliano GA, Braun N, Remuzzi G. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis. 2004;44(3):385–401.

    Article  PubMed  Google Scholar 

  31. Praga M, Barrio V, Juarez GF, Luno J, Grupo Espanol de Estudio de la Nefropatia M. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int. 2007;71(9):924–30.

    Article  CAS  PubMed  Google Scholar 

  32. Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, et al. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. Am J Med Sci. 2010;339(3):233–8.

    Article  PubMed  Google Scholar 

  33. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int. 1995;47(4):1130–5.

    Article  CAS  PubMed  Google Scholar 

  34. Vivarelli M, Massella L, Ruggiero B, Emma F. Minimal change disease. Clin J Am Soc Nephrol. 2017;12(2):332–45.

    Article  CAS  PubMed  Google Scholar 

  35. Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, et al. Adult minimal-change disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol. 2007;2(3):445–53.

    Article  CAS  PubMed  Google Scholar 

  36. Tse KC, Lam MF, Yip PS, Li FK, Choy BY, Lai KN, et al. Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc. 2003;18(7):1316–20.

    Google Scholar 

  37. D’Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med. 2011;365(25):2398–411.

    Article  PubMed  Google Scholar 

  38. Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017;12(3):502–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science. 2010;329(5993):841–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Shi L. Anti-neutrophil cytoplasmic antibody-associated vasculitis: prevalence, treatment, and outcomes. Rheumatol Int. 2017;37(11):1779–88.

    Article  CAS  PubMed  Google Scholar 

  41. Jennette JC, Wilkman AS, Falk RJ. Diagnostic predictive value of ANCA serology. Kidney Int. 1998;53(3):796–8.

    Article  CAS  PubMed  Google Scholar 

  42. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21(10):1628–36.

    Article  PubMed  Google Scholar 

  43. Tanna A, Guarino L, Tam FW, Rodriquez-Cubillo B, Levy JB, Cairns TD, et al. Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc. 2015;30(7):1185–92.

    CAS  Google Scholar 

  44. Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol. 1996;7(1):33–9.

    CAS  PubMed  Google Scholar 

  45. McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12(7):1162–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A, et al. Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol. 2011;22(1):187–95.

    Article  PubMed  Google Scholar 

  47. Rodriguez-Iturbe B, Musser JM. The current state of poststreptococcal glomerulonephritis. J Am Soc Nephrol. 2008;19(10):1855–64.

    Article  PubMed  Google Scholar 

  48. Nasr SH, D’Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Pract. 2011;119(1):c18–25. discussion c6

    Article  CAS  PubMed  Google Scholar 

  49. Oshima Y, Moriyama T, Itabashi M, Takei T, Nitta K. Characteristics of IgA nephropathy in advanced-age patients. Int Urol Nephrol. 2015;47(1):137–45.

    Article  CAS  PubMed  Google Scholar 

  50. Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014–21.

    Article  PubMed  Google Scholar 

  51. Steiner N, Gobel G, Suchecki P, Prokop W, Neuwirt H, Gunsilius E. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients. Oncotarget. 2018;9(2):2344–56.

    Article  PubMed  Google Scholar 

  52. Bridoux F, Leung N, Hutchison CA, Touchard G, Sethi S, Fermand JP, et al. Diagnosis of monoclonal gammopathy of renal significance. Kidney Int. 2015;87(4):698–711.

    Article  CAS  PubMed  Google Scholar 

  53. Kumar SK, Rajkumar V, Kyle RA, van Duin M, Sonneveld P, Mateos MV, et al. Multiple myeloma. Nat Rev Dis Primers. 2017;3:17046.

    Article  PubMed  Google Scholar 

  54. Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention. Br J Clin Pharmacol. 2006;61(5):494–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Mangoni AA, Jackson SH. The implications of a growing evidence base for drug use in elderly patients part 2. ACE inhibitors and angiotensin receptor blockers in heart failure and high cardiovascular risk patients. Br J Clin Pharmacol. 2006;61(5):502–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Timlin H, Lee SM, Manno RL, Seo P, Geetha D. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis. Semin Arthritis Rheum. 2015;45(1):67–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. West London Renal and Transplant Centre, Hammersmith Hospital, Imperial NHS Healthcare Trust, London, UK

    Arunraj Navaratnarajah & Michelle Willicombe

Authors
  1. Arunraj Navaratnarajah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle Willicombe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Arunraj Navaratnarajah or Michelle Willicombe .

Editor information

Editors and Affiliations

  1. Nephrology Division, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Carlos Guido Musso

  2. Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    José Ricardo Jauregui

  3. Departamento de Medicina, Salamanca, Spain

    Juan Florencio Macías-Núñez

  4. University of Medicine “Grigore T. Popa” and University Hospital “C. I. Parhon”, Iasi, Romania

    Adrian Covic

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Navaratnarajah, A., Willicombe, M. (2019). Glomerulopathies in the Elderly. In: Musso, C., Jauregui, J., Macías-Núñez, J., Covic, A. (eds) Clinical Nephrogeriatrics. Springer, Cham. https://doi.org/10.1007/978-3-030-18711-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18711-8_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18710-1

  • Online ISBN: 978-3-030-18711-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation